Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?

Autor: Ocak B; Department of Medical Oncology, Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa 16350, Turkey., Sahin AB; Department of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey., Ertürk I; Department of Medical Oncology, Gulhane School of Medicine, University of Health Sciences, Ankara 06018, Turkey., Korkmaz M; Department of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42090, Turkey., Erdem D; Department of Medical Oncology, VM Medical Park Samsun Hospital, Samsun 55200, Turkey., Cakıroglu U; Department of Medical Oncology, Van Training and Research Hospital, University of Health Sciences, Van 65300, Turkey., Karaca M; Department of Medical Oncology, Antalya Training and Research Hospital, University of Health Sciences, Antalya 07100, Turkey., Dirican A; Department of Medical Oncology, School of Medicine, Celal Bayar University, Manisa 45140, Turkey., Olmez OF; Department of Medical Oncology, Medipol University Hospital, Istanbul 34810, Turkey., Goktas Aydın S; Department of Medical Oncology, Medipol University Hospital, Istanbul 34810, Turkey., Gökyer A; Department of Medical Oncology, Department of Internal Medicine, School of Medicine, Trakya University, Edirne 22130, Turkey., Kücükarda A; Department of Medical Oncology, Department of Internal Medicine, School of Medicine, Trakya University, Edirne 22130, Turkey., Gülmez A; Department of Medical Oncology, School of Medicine, Inonu University, Malatya 44280, Turkey., Yumuk PF; Department of Medical Oncology, School of Medicine, Marmara University, Istanbul 34854, Turkey., Demircan NC; Department of Medical Oncology, School of Medicine, Marmara University, Istanbul 34854, Turkey., Oyman A; Department of Medical Oncology, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul 34764, Turkey., Sakalar T; Department of Medical Oncology, Necip Fazıl City Hospital, Kahramanmaraş 46050, Turkey., Karatas F; Department of Medical Oncology, Faculty of Medicine, Karabuk University, Karabuk 78100, Turkey., Demir H; Department of Medical Oncology, Afyonkarahisar Health Sciences University, Afyon 03030, Turkey., Yasin AI; Department of Medical Oncology, Faculty of Medicine, Bezmialem Vakif University, Istanbul 34093, Turkey., Deligonul A; Department of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey., Dakiki B; Department of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey., Goktug MR; Department of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey., Avcı O; Department of Medical Oncology, Tekirdağ Namık Kemal University, Tekirdağ 34093, Turkey., Tacar SY; Department of Medical Oncology, Tekirdağ Namık Kemal University, Tekirdağ 34093, Turkey., Turhal NS; Department of Medical Oncology, Anadolu Health Center, Kocaeli 2255, Turkey., Deniz GI; Department of Medical Oncology, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul 34371, Turkey., Kacan T; Department of Medical Oncology, Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa 16350, Turkey., Cubukcu E; Department of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey., Evrensel T; Department of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey.

Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Sep 04; Vol. 31 (9), pp. 5195-5205. Date of Electronic Publication: 2024 Sep 04.

Evaluation of Predictive and Prognostic Importance of Lung Immune Prognostic Index in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.

Autor: Arıkan R; Department of Medical Oncology, Marmara University School of Medicine, Istanbul, TUR., Alkış H; Department of Radiation Oncology, Marmara University School of Medicine, Istanbul, TUR., Işık S; Department of Medical Oncology, Marmara University School of Medicine, Istanbul, TUR., Yaşar A; Department of Medical Oncology, Marmara University School of Medicine, Istanbul, TUR., Çelebi A; Department of Medical Oncology, Marmara University School of Medicine, Istanbul, TUR., Majidova N; Department of Medical Oncology, Marmara University School of Medicine, Istanbul, TUR., Sever N; Department of Medical Oncology, Marmara University School of Medicine, Istanbul, TUR., Adlı M; Department of Radiation Oncology, Marmara University School of Medicine, Istanbul, TUR., Demircan NC; Department of Medical Oncology, Erzurum Education and Training Hospital, Erzurum, TUR.

Publikováno v: Cureus [Cureus] 2023 Jun 17; Vol. 15 (6), pp. e40548. Date of Electronic Publication: 2023 Jun 17 (Print Publication: 2023).

Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities.

Autor: Telli TA; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey. Electronic address: tugbaakintelli@gmail.com., Alan O; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey; Department of Medical Oncology, Faculty of Medicine, Koç University, Istanbul, Turkey., Demircan NC; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Sariyar N; Department of Internal Medicine, Faculty of Medicine, Marmara University, Istanbul, Turkey., Arikan R; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Basoglu T; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Yasar A; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Celebi A; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Isik S; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Sofulu O; Department of Orthopaedic Surgery and Traumatology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Erol B; Department of Orthopaedic Surgery and Traumatology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Turkoz HK; Department of Pathology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Ozgen Z; Department of Radiation Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Ercelep O; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Dane F; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey., Yumuk PF; Department of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey; Department of Medical Oncology, Faculty of Medicine, Koç University, Istanbul, Turkey.

Publikováno v: Orthopaedics & traumatology, surgery & research : OTSR [Orthop Traumatol Surg Res] 2023 May; Vol. 109 (3), pp. 103491. Date of Electronic Publication: 2022 Nov 28.

Prognostic value of Gustave Roussy immune score in operable pancreatic adenocarcinoma.

Autor: Basoglu T; Department of Medical Oncology, Marmara University School of Medicine, Turkey., Babacan NA; Medical Oncology, Bahrain Oncology Center, Bahrain., Ozturk FE; Internal Medicine, Marmara University School of Medicine, Marmara University, Turkey., Arikan R; Department of Medical Oncology, Marmara University School of Medicine, Turkey., Demircan NC; Department of Medical Oncology, Marmara University School of Medicine, Turkey., Telli TA; Department of Medical Oncology, Marmara University School of Medicine, Turkey., Ercelep O; Department of Medical Oncology, Marmara University School of Medicine, Turkey., Dane F; Department of Medical Oncology, Marmara University School of Medicine, Turkey., Yumuk PF; Department of Medical Oncology, Marmara University School of Medicine, Turkey.

Publikováno v: Indian journal of cancer [Indian J Cancer] 2023 Apr-Jun; Vol. 60 (2), pp. 179-184.

Dynamic changes in systemic immune-inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy.

Autor: Demircan NC; Department of Medical Oncology, Erzurum Regional Training and Research Hospital, Erzurum, Turkey., Atcı MM; Department of Medical Oncology, Prof. Dr. Cemil Taşçıoğlu State Hospital, Istanbul, Turkey., Demir M; Department of Medical Oncology, Erzurum Regional Training and Research Hospital, Erzurum, Turkey., Işık S; Department of Medical Oncology, Erzurum Regional Training and Research Hospital, Erzurum, Turkey., Akagündüz B; Department of Medical Oncology, Binali Yıldırım University School of Medicine, Erzincan, Turkey.

Publikováno v: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2023 Feb; Vol. 19 (1), pp. 104-112. Date of Electronic Publication: 2022 May 10.